liso-cel Archives -

Bristol-Myers Squibb finally has FDA approval for its CAR-T therapy liso-cel, which has been cleared by the US

BMS finally gets FDA OK for liso-cel, sets $410k launch price

https://pharmaphorum.com/news/bms-finally-gets-fda-ok-for-liso-cel-sets-410k-launch-price/

Bristol-Myers Squibb posted a solid set of financial results for the third quarter, but shares slid on investor

Could an FDA inspection scupper CVR deadline for BMS’ liso-cel?

https://pharmaphorum.com/news/could-an-fda-inspection-scupper-cvr-deadline-for-bms-liso-cel/

Bristol-Myers Squibb’s risky three-drug bet with former shareholders in Celgene is still on – but it could be

Concerns over BMS and Celgene merger payout as FDA extends drug review

https://pharmaphorum.com/news/concerns-over-bms-and-celgene-merger-payout-as-fda-extends-drug-review/

liso-cel